CURX Dividend: Curanex Pharmaceuticals Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

CURX Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	12/31/2024	12/31/2023	12/31/2022
Revenue	0	0	0
Revenue Growth (YoY)	--	--	--
Cost of Revenue	--	0	0
Gross Profit	--	0	0
Selling, General & Admin	0	0	0
Research & Development	--	--	--
Operating Expenses	0	0	0
Other Non Operating Income (Expenses)	0	0	0
Pretax Income	0	0	0
Income Tax Expense	--	--	--
Net Income	0	0	0
Net Income Growth	--	--	--
Shares Outstanding (Diluted)	27.75	27.75	42
Shares Change (YoY)	0%	-34%	--
EPS (Diluted)	-0.01	0	0
EPS Growth	1,757%	40%	--
Free Cash Flow	0	0	0
Free Cash Flow Per Share	0	0	0
Gross Margin	--	0%	0%
Operating Margin	0%	0%	0%
Profit Margin	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%
EBITDA	--	--	--
EBITDA Margin	--	--	--
D&A For EBITDA	--	--	--
EBIT	0	0	0
EBIT Margin	0%	0%	0%
Effective Tax Rate	--	--	--